Literature DB >> 25398478

The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate.

Roberto Depasquale1, Sau L Lee, Bhawana Saluja, Jagdeep Shur, Robert Price.   

Abstract

This study investigated the structural relaxation of micronized fluticasone propionate (FP) under different lagering conditions and its influence on aerodynamic particle size distribution (APSD) of binary and tertiary carrier-based dry powder inhaler (DPI) formulations. Micronized FP was lagered under low humidity (LH 25 C, 33% RH [relative humidity]), high humidity (HH 25°C, 75% RH) for 30, 60, and 90 days, respectively, and high temperature (HT 60°C, 44% RH) for 14 days. Physicochemical, surface interfacial properties via cohesive-adhesive balance (CAB) measurements and amorphous disorder levels of the FP samples were characterized. Particle size, surface area, and rugosity suggested minimal morphological changes of the lagered FP samples, with the exception of the 90-day HH (HH90) sample. HH90 FP samples appeared to undergo surface reconstruction with a reduction in surface rugosity. LH and HH lagering reduced the levels of amorphous content over 90-day exposure, which influenced the CAB measurements with lactose monohydrate and salmeterol xinafoate (SX). CAB analysis suggested that LH and HH lagering led to different interfacial interactions with lactose monohydrate but an increasing adhesive affinity with SX. HT lagering led to no detectable levels of the amorphous disorder, resulting in an increase in the adhesive interaction with lactose monohydrate. APSD analysis suggested that the fine particle mass of FP and SX was affected by the lagering of the FP. In conclusion, environmental conditions during the lagering of FP may have a profound effect on physicochemical and interfacial properties as well as product performance of binary and tertiary carrier-based DPI formulations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25398478      PMCID: PMC4444627          DOI: 10.1208/s12249-014-0222-8

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  16 in total

1.  Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations.

Authors:  Harshal A Kubavat; Jagdeep Shur; Graham Ruecroft; David Hipkiss; Robert Price
Journal:  Pharm Res       Date:  2011-12-09       Impact factor: 4.200

2.  Conditioning following powder micronization: influence on particle growth of salbutamol sulfate.

Authors:  Katharina Brodka-Pfeiffer; Heribert Häusler; Peter Grass; Peter Langguth
Journal:  Drug Dev Ind Pharm       Date:  2003-11       Impact factor: 3.225

3.  The cohesive-adhesive balances in dry powder inhaler formulations II: influence on fine particle delivery characteristics.

Authors:  Philippe Begat; David A V Morton; John N Staniforth; Robert Price
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

4.  An investigation into the dispersion mechanisms of ternary dry powder inhaler formulations by the quantification of interparticulate forces.

Authors:  Matthew D Jones; Jennifer C Hooton; Michelle L Dawson; Alan R Ferrie; Robert Price
Journal:  Pharm Res       Date:  2007-10-19       Impact factor: 4.200

Review 5.  Drug mechanochemical activation.

Authors:  I Colombo; G Grassi; M Grassi
Journal:  J Pharm Sci       Date:  2009-11       Impact factor: 3.534

6.  Mechanical activation of pharmaceutical systems.

Authors:  R Hüttenrauch; S Fricke; P Zielke
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

7.  Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability.

Authors:  G H Ward; R K Schultz
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

8.  Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: an AFM and Raman investigation.

Authors:  Philippe G A Rogueda; Robert Price; Tim Smith; Paul M Young; Daniela Traini
Journal:  J Colloid Interface Sci       Date:  2011-05-31       Impact factor: 8.128

9.  Towards an understanding of the structurally based potential for mechanically activated disordering of small molecule organic crystals.

Authors:  Peter L D Wildfong; Bruno C Hancock; Michael D Moore; Kenneth R Morris
Journal:  J Pharm Sci       Date:  2006-12       Impact factor: 3.534

10.  Increase in the specific surface area of budesonide during storage postmicronization.

Authors:  Vidya Joshi; Sarvajna Dwivedi; Gary H Ward
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

View more
  3 in total

Review 1.  Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products.

Authors:  Bryan Newman; Kimberly Witzmann
Journal:  Pharmaceut Med       Date:  2020-04

Review 2.  Physical stability of dry powder inhaler formulations.

Authors:  Nivedita Shetty; David Cipolla; Heejun Park; Qi Tony Zhou
Journal:  Expert Opin Drug Deliv       Date:  2019-12-13       Impact factor: 6.648

3.  A Systematic Approach in the Development of the Morphologically-Directed Raman Spectroscopy Methodology for Characterizing Nasal Suspension Drug Products.

Authors:  Gonçalo Farias; Jagdeep Shur; Robert Price; Elizabeth Bielski; Bryan Newman
Journal:  AAPS J       Date:  2021-05-18       Impact factor: 4.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.